Pictet Asset Management Portfolio holdings
AUM
$104B
1-Year Est. Return
22.23%
1 Year Est. Return
+22.23%
AUM
$104B
AUM Growth
+$5.37B
(+5.5%)
Holding
2,088
Top Buys
| 1 | +$418M | |
| 2 | +$392M | |
| 3 | +$271M | |
| 4 |
Dynatrace
DT
|
+$183M |
| 5 |
ServiceNow
NOW
|
+$176M |
Top Sells
| 1 | +$460M | |
| 2 | +$293M | |
| 3 | +$273M | |
| 4 |
Marvell Technology
MRVL
|
+$263M |
| 5 |
CyberArk
CYBR
|
+$211M |
Sector Composition
| 1 | Technology | 35.81% |
| 2 | Industrials | 15.44% |
| 3 | Healthcare | 11.6% |
| 4 | Financials | 8.09% |
| 5 | Consumer Discretionary | 7.4% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
326
Infosys
INFY
$75.4B
| $49.9M | 0.05% |
3,066,545
-872,448
|
|
||
327
West Pharmaceutical
WST
$18.7B
| $49.9M | 0.05% |
190,113
-20,389
|
|
||
328
Elevance Health
ELV
$83.3B
| $49.8M | 0.05% |
154,171
-29,830
|
|
||
329
Scholar Rock
SRRK
$4.59B
| $49.3M | 0.05% |
1,322,931
+335,467
|
|
||
330
Prudential Financial
PRU
$39.1B
| $48.5M | 0.05% |
467,360
+101,354
|
|
||
331
Deutsche Bank
DB
$74.3B
| $48.4M | 0.05% |
1,374,281
+53,093
|
|
||
332
Enbridge
ENB
$104B
| $48.2M | 0.05% |
955,608
-206
|
|
||
333
BioMarin Pharmaceuticals
BMRN
$10.5B
| $48.2M | 0.05% |
890,213
-203,165
|
|
||
334
3M
MMM
$89.1B
| $48M | 0.05% |
309,256
-6,752
|
|
||
335
PNC Financial Services
PNC
$90.2B
| $47.9M | 0.05% |
238,401
-7,433
|
|
||
336
W.W. Grainger
GWW
$50.8B
| $47.4M | 0.05% |
49,736
+4,008
|
|
||
337
Agnico Eagle Mines
AEM
$99.1B
| $47.4M | 0.05% |
281,278
-1,313
|
|
||
338
Albemarle
ALB
$19.2B
| $46.7M | 0.05% |
575,820
-13,330
|
|
||
339
Ventas
VTR
$36.9B
| $46.5M | 0.04% |
664,533
-43,735
|
|
||
340
Valero Energy
VLO
$56B
| $45.4M | 0.04% |
266,802
+78,822
|
|
||
341
Travelers Companies
TRV
$60.1B
| $45.3M | 0.04% |
162,292
-528
|
|
||
342
Emcor
EME
$31.3B
| $44.9M | 0.04% |
69,154
+2,207
|
|
||
343
TransDigm Group
TDG
$81.7B
| $44.8M | 0.04% |
33,987
+7,195
|
|
||
344
CRH
CRH
$82.2B
| $44.4M | 0.04% |
370,584
+45,964
|
|
||
|
AKRO
345
DELISTED
Akero Therapeutics
AKRO
| $44M | 0.04% |
926,441
-60,192
|
|
||
346
Ultragenyx Pharmaceutical
RARE
$2.17B
| $44M | 0.04% |
1,458,187
-241,757
|
|
||
347
Brookfield
BN
$106B
| $44M | 0.04% |
961,341
+35,556
|
|
||
348
Axsome Therapeutics
AXSM
$8.94B
| $44M | 0.04% |
362,138
-49,712
|
|
||
349
Cognizant
CTSH
$40.9B
| $43.7M | 0.04% |
652,207
+37,162
|
|
||
350
On Holding
ONON
$14.9B
| $43.6M | 0.04% |
1,029,798
+82,550
|
|